Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer

Fam Cancer. 2021 Oct;20(4):289-291. doi: 10.1007/s10689-021-00228-2. Epub 2021 Feb 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Predisposition to Disease
  • Genetic Testing
  • Humans
  • Neoplasms* / diagnosis
  • Neoplasms* / genetics
  • Neoplastic Syndromes, Hereditary* / diagnosis
  • Neoplastic Syndromes, Hereditary* / genetics